GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.Read More »
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Tagged with: Accutane adverse events Avandia Bayer Chantix Coumadin drug litigation FDA Food and Drug Administration GlaxoSmithKline Hoffman-LaRoche Institute for Safe Medication Practices Johnson & Johnson Levaquin Pfizer Pradaxa prescription drugs Reglan Wyeth Yasmin YazRead More »
Federal law preempts state product liability claims brought by a man who suffered paralysis after a Medtronic pain pump was surgically implanted to deliver medication to his spine, the 9th Circuit has ruled in affirming a dismissal.Read More »
The Food and Drug Administration has rejected a consumer safety group’s call for an immediate ban of bisphenol A (BPA) in food and food packaging, concluding that further scientific study into the chemical’s effects on human health is needed.Read More »
What are believed to be the first three product liability suits over the blood thinner Pradaxa were filed earlier this month in federal courts in Kentucky, Louisiana and Tennessee.Read More »